Norton Rose Fulbright has advised Profil Institut für Stoffwechselforschung GmbH. Profil Institut für Stoffwechselforschung GmbH has completed the acquisition of US-based clinical research organisation Tranquil Clinical...
Profil Acquires US-Based Tranquil Clinical and Research Consulting Services
Armira’s Strategic Partnership With OSYPKA
Norton Rose Fulbright advised Armira on the deal. Armira signed a strategic partnership with OSYPKA AG, a leading German MedTech company providing mission critical cardio products...
Pure Health Capital’s US$500 Million Investment In Ardent Health Partners L.L.C
Norton Rose Fulbright has advised Alpha Dhabi Holding subsidiary Pure Health Capital on the deal. Pure Health Capital (Pure Health) signed a series of agreements related...



























